{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:14:29Z","timestamp":1780636469057,"version":"3.54.1"},"reference-count":30,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1136\/bjophthalmol-2017-310157","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T00:10:49Z","timestamp":1492042249000},"page":"1720-1724","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Distinct clinical characteristics of atypical optic neuritis with seronegative aquaporin-4 antibody among Chinese patients"],"prefix":"10.1136","volume":"101","author":[{"given":"Huanfen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahe","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanping","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,4,12]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2017-310157-1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/NRL.0b013e31816f27fe","article-title":"Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations","volume":"14","author":"Abou Zeid","year":"2008","journal-title":"Neurologist"},{"key":"key-10.1136\/bjophthalmol-2017-310157-2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00041327-200112000-00015","article-title":"Optic neuritis: historical aspects","volume":"21","author":"Volpe","year":"2001","journal-title":"J Neuroophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2007.08.004","article-title":"Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial","volume":"115","year":"2008","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2017-310157-5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-7","doi-asserted-by":"crossref","DOI":"10.1111\/nyas.12794","article-title":"Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later","volume":"1366","author":"Pittock","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.1136\/bjophthalmol-2017-310157-8","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"key":"key-10.1136\/bjophthalmol-2017-310157-9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"key-10.1136\/bjophthalmol-2017-310157-10","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00415-016-8155-7","article-title":"Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages","volume":"263","author":"Zhou","year":"2016","journal-title":"J Neurol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-11","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00415-015-7844-y","article-title":"Features of anti-aquaporin 4 antibody-seropositive chinese patients with neuromyelitis optica spectrum optic neuritis","volume":"262","author":"Li","year":"2015","journal-title":"J Neurol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2011.08.030","article-title":"Optic neuritis in an ethnically diverse population: higher risk of atypical cases in patients of African or African-Caribbean heritage","volume":"312","author":"Storoni","year":"2012","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/bjophthalmol-2017-310157-13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. the optic neuritis study group","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2017-310157-14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-013-6957-4","article-title":"Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported","volume":"261","author":"Petzold","year":"2014","journal-title":"J Neurol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-15","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00415-015-7844-y","article-title":"Features of anti-aquaporin 4 antibody-seropositive Chinese patients with neuromyelitis optica spectrum optic neuritis","volume":"262","author":"Li","year":"2015","journal-title":"J Neurol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-16","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/WNO.0000000000000180","article-title":"Atypical optic neuritis","volume":"34","author":"Warren","year":"2014","journal-title":"J Neuroophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jns.2011.03.021","article-title":"Clinical characteristics, therapeutic outcomes of isolated atypical optic neuritis in China","volume":"305","author":"Lai","year":"2011","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/bjophthalmol-2017-310157-18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nyas.12794","article-title":"Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later","volume":"1366","author":"Pittock","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.1136\/bjophthalmol-2017-310157-19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","article-title":"Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis","volume":"81","author":"Petzold","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/bjophthalmol-2017-310157-20","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the Optic neuritis treatment trial. Optic neuritis study group","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s10384-005-0281-1","article-title":"Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan","volume":"50","author":"Lin","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archneurol.2012.249","article-title":"Effects of age and sex on aquaporin-4 autoimmunity","volume":"69","author":"Quek","year":"2012","journal-title":"Arch Neurol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-23","first-page":"553","article-title":"[Chronic relapsing inflammatory optic neuropathy (CRION) without detection of IgG-NMO antibodies]","volume":"22","author":"P\u00e9rez-D\u00edaz","year":"2007","journal-title":"Neurologia"},{"key":"key-10.1136\/bjophthalmol-2017-310157-24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION)","volume":"126","author":"Kidd","year":"2003","journal-title":"Brain"},{"key":"key-10.1136\/bjophthalmol-2017-310157-25","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/archopht.1991.01080120052024","article-title":"Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles","volume":"109","author":"Rizzo","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310157-26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.autrev.2015.12.004","article-title":"Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination","volume":"15","author":"Ramanathan","year":"2016","journal-title":"Autoimmun Rev"},{"key":"key-10.1136\/bjophthalmol-2017-310157-27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007766","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis","volume":"5","author":"Nakajima","year":"2015","journal-title":"BMJ Open"},{"key":"key-10.1136\/bjophthalmol-2017-310157-28","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1212\/NXI.0000000000000040","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"Ramanathan","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"key-10.1136\/bjophthalmol-2017-310157-29","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","article-title":"Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica","volume":"81","author":"Jiao","year":"2013","journal-title":"Neurology"},{"key":"key-10.1136\/bjophthalmol-2017-310157-30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.survophthal.2012.09.001","article-title":"Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management","volume":"58","author":"Rahimy","year":"2013","journal-title":"Surv Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-310157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:54:55Z","timestamp":1601110495000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-310157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,12]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,11,23]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1136\/bjophthalmol-2017-310157"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310157","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,12]]}}}